By InvitationPhase 4

Laparoscopic TAP Block During Robotic Assisted Laparoscopic Radical Prostatectomy for Improvement in Postoperative Pain

United States94 participantsStarted 2024-02-19

Plain-language summary

Determine the impact of a laparoscopic-guided transversus abdominis plane (TAP) block timing (at initiation or conclusion of procedure) on the postoperative pain experience in patients following robot assisted laparoscopic radical prostatectomy (RALP).

Who can participate

Age range18 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Able to read, understand, and provide written, dated, informed consent prior to screening, complete study form(s) independently, comply with study protocol, and communicate with study personnel about clinically important information.
✓. Men ≥ 18 years of age.
✓. Pathologically confirmed diagnosis of prostate cancer
✓. Scheduled for routine RALP

Exclusion criteria

✕. Chronic opioid use (daily for \&gt;3 months)
✕. Weight \&lt;40 kilograms
✕. Any condition that causes a lack of normal sensation to the abdomen or pelvis
✕. Current or history of any physical condition that, in the investigator's opinion, might put the subject at risk or interfere with study results interpretation

What they're measuring

Compare laparoscopic-guided TAP block timing (at initiation "early" or conclusion "late" of procedure) on the postoperative pain levels reported in patients following robot assisted laparoscopic radical prostatectomy (RALP).

Timeframe: 24 hours after RALP

Trial details

NCT IDNCT05753046

SponsorCorewell Health East

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2028-08

View on ClinicalTrials.gov More Prostate Cancer trials